Assignee
TRIS PHARMA INC
US·47 granted patents·22 pending applications·1,549 citations·filing 2012–2025
Top patents by PatentIndex Score
69 records- 0199US10933143B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2019·Granted Mar 2, 2021·36 cites·22 claims
- 0299US10668163B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2019·Granted Jun 2, 2020·36 cites·27 claims
- 0399US10172958B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jan 8, 2019·37 cites·23 claims
- 0499US10086087B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2017·Granted Oct 2, 2018·36 cites·22 claims
- 0599US9675703B2Modified release formulations containing drug - ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jun 13, 2017·49 cites·21 claims
- 0699US9675704B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jun 13, 2017·49 cites·20 claims
- 0799US9549989B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jan 24, 2017·40 cites·14 claims
- 0899US9522191B2Modified release formulations containing drug—ion exchange resin complexesTRIS PHARMA INC·Filed 2014·Granted Dec 20, 2016·40 cites·19 claims
- 0999US9198864B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2015·Granted Dec 1, 2015·55 cites·14 claims
- 1099US8883217B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2014·Granted Nov 11, 2014·57 cites·18 claims
- 1199US8790700B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Jul 29, 2014·70 cites·29 claims
- 1299US8747902B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Jun 10, 2014·70 cites·30 claims
- 1399US8597684B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Dec 3, 2013·77 cites·29 claims
- 1499US8491935B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2012·Granted Jul 23, 2013·95 cites·24 claims
- 1598US10857143B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2019·Granted Dec 8, 2020·45 cites·27 claims
- 1698US10507203B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2018·Granted Dec 17, 2019·42 cites·19 claims
- 1798US9844545B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2017·Granted Dec 19, 2017·43 cites·30 claims
- 1898US9844544B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2016·Granted Dec 19, 2017·46 cites·40 claims
- 1998US9545399B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2016·Granted Jan 17, 2017·50 cites·27 claims
- 2098US9295642B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2015·Granted Mar 29, 2016·61 cites·29 claims
- 2198US9180100B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2015·Granted Nov 10, 2015·55 cites·30 claims
- 2298US9040083B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2014·Granted May 26, 2015·51 cites·22 claims
- 2398US8999386B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2014·Granted Apr 7, 2015·56 cites·30 claims
- 2498US8956649B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2014·Granted Feb 17, 2015·51 cites·43 claims
- 2598US8778390B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2013·Granted Jul 15, 2014·62 cites·30 claims
- 2698US8563033B1Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2013·Granted Oct 22, 2013·67 cites·19 claims
- 2797US11103494B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2020·Granted Aug 31, 2021·5 cites·30 claims
- 2897US11103495B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2021·Granted Aug 31, 2021·5 cites·30 claims
- 2996US9867797B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2016·Granted Jan 16, 2018·38 cites·41 claims
- 3096US9408823B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2015·Granted Aug 9, 2016·44 cites·21 claims
- 3196US9180104B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2014·Granted Nov 10, 2015·59 cites·30 claims
- 3288US11241411B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2019·Granted Feb 8, 2022·3 cites·20 claims
- 3387US11337920B2Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug releaseTRIS PHARMA INC·Filed 2018·Granted May 24, 2022·7 cites·16 claims
- 3487US2023233542A1Methylphenidate Extended Release Chewable TabletTRIS PHARMA INC·Filed 2023·Application pending·0 cites
- 3585US11666546B2GHB pharmaceutical compositions comprising a floating interpenetrating polymer network forming systemTRIS PHARMA INC·Filed 2018·Granted Jun 6, 2023·5 cites·19 claims
- 3684US11337919B2Modified release drug powder composition comprising gastro-retentive RAFT forming systems having trigger pulse drug releaseTRIS PHARMA INC·Filed 2018·Granted May 24, 2022·5 cites·18 claims
- 3784US2022168432A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2022·Application pending·0 cites
- 3883US11590081B1Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2018·Granted Feb 28, 2023·1 cites·37 claims
- 3983US11590228B1Extended release amphetamine compositionsTRIS PHARMA INC·Filed 2019·Granted Feb 28, 2023·1 cites·18 claims
- 4081US2025064747A1Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2024·Application pending·0 cites
- 4180US12076441B2Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2023·Granted Sep 3, 2024·0 cites·6 claims
- 4280US2023165837A1Novel clonidine formulationTRIS PHARMA INC·Filed 2022·Application pending·0 cites
- 4379US2019151460A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2019·Application pending·0 cites
- 4479US2021162055A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2021·Application pending·0 cites
- 4577US11633389B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2020·Granted Apr 25, 2023·0 cites·30 claims
- 4677US2021038734A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2020·Application pending·0 cites
- 4775US2025099376A1Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug releaseTRIS PHARMA INC·Filed 2024·Application pending·0 cites
- 4875US2018000954A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2017·Application pending·0 cites
- 4972US2017319566A1Methylphenidate Extended Release Chewable TabletTRIS PHARMA INC·Filed 2017·Application pending·0 cites
- 5072US2023233683A1Extended release amphetamine compositionsTRIS PHARMA INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →